Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederjamanetwork.com
JAMA Current Issue
Get the latest updates from JAMA Current Issue directly as they happen.
Follow now 532 followers
Latest posts
Last updated 2 days ago
Point-of-Care Testing to Combat Congenital Syphilis—The Time Is Now
2 days ago
This Viewpoint highlights the importance of point-of-care tests to detect syphilis, leading...
The 2025-2030 Dietary Guidelines—Time for Real Progress
2 days ago
This Viewpoint discusses the 2025-2030 Dietary Guidelines for Americans report and highlights...
Optimizing the National Response to the Syphilis and Congenital Syphilis Syndemic
2 days ago
This Viewpoint discusses the rising rates of syphilis cases in the US...
CMS Innovation Center’s Role in Addressing Emissions
2 days ago
This Viewpoint discusses a Centers for Medicare and Medicaid Innovation volunteer greenhouse...
Platform Clinical Trials for the Efficient Evaluation of Multiple Treatments
2 days ago
This Guide to Statistics and Methods provides an overview of platform trials...
Adjuvant Atezolizumab for Triple-Negative Breast Cancer
2 days ago
This randomized clinical trial investigates whether adding immune therapy to adjuvant chemotherapy...
Pridopidine in Amyotrophic Lateral Sclerosis
2 days ago
This randomized platform trial investigates whether pridopidine, a sigma-1 receptor agonist, impacted...
CNM-Au8 in Amyotrophic Lateral Sclerosis
2 days ago
This randomized, multicenter platform trial investigates the efficacy of CNM-Au8, an oral...
Platform Trials in ALS
2 days ago
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive...
Rethinking Adjuvant Immune Therapy for Triple Negative Breast Cancer
2 days ago
Immunotherapy stands as one of the most transformative breakthroughs in modern cancer...
Breast Cancer and Levonorgestrel-Releasing Intrauterine Systems—Reply
2 days ago
In Reply We appreciate the comments about our recent study.
Cost Sharing for Preferred Branded Drugs in Medicare Part D
2 days ago
This study uses data from the Centers for Medicare & Medicaid Services...